DOCSLIB.ORG

LEVEL LASER Therapy CLINICAL EVIDENCE Content

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

LOW - LEVEL LASER THeraPY CLINICAL EVIDENCE CONTENT 1. Low-Level Laser Therapy in Rehabilitation 4 Additive effects of low-level laser therapy with exercise on subacromial syndrom: A randomised, double-blind, controlled trial 4 Efficacy of low-level laser therapy in the management of neck pain: A systematic review and meta-analysis of randomised placebo or active-treatment controlled trials 5 Evaluation of low-level therapy effectiveness on the pain and masticatory performance of patients with myofascial pain 6 A randomised, placebo controlled trial of low-level laser therapy for activated achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations 7 Effect of low–level laser therapy on the expression of inflammatory mediators and on neutrophils and macrophages in acute joint inflammation 8 Effectiveness of physiotherapy and GaAIAs laser in the management of temporomandibular joint disorders 9 Evaluation of low-level laser therapy in TMD patients – A case report 10 A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders 11 Role of low-level laser therapy in neurorehabilitation 12 2. Low-Level Laser Therapy in Dermatology 13 Low-level laser therapy in skin – Stimulating, Healing, Restoring 13 Low-level laser therapy – A conservative approach to the burn scar 14 Prophylactic low-level light therapy for the treatment of hypertrophic scars and keloids – A case series 15 Effects of low–level laser therapy on the progress of wound healing in humans: The contribution of in vitro and in vivo experimental studies 16 Effect of laser phototherapy on reccuring herpes labialis prevention – An in vivo study 17 Blue and red light combination led phototherapy for acne vulgaris in patients with skin phototype IV 18 Helium-neon laser irradiaton stimulates migration and proliferation in melanocytes and induces repigmentation in segmental – type vitiligo 20 The use of laser acupuncture for the treatment of neurogenic pruritus in a child – A case history 21 3. Low-Level Laser Therapy in Otorhinolaryngology 22 Effects of Low-level laser therapy on ovalbumin-induced mouse model of allergic rhinitis 22 Low-level laser therapy of sinusitis 23 Potential anti-inflammatory effect of Low-level laser therapy on the experimental reflux laryngitis: A preliminary study 24 Low–level laser therapy in patients with complaints of tinnitus – A clinical study 25 Low-level laser for treatment of tinnitus: A self-controlled clinical trial 26 4. Low-Level Laser Therapy in Dentistry 27 A clinical investigation of Low-level laser irradiation on hypersensitive dentine 27 The effect of Low-level laser therapy during orthodontic movement – A preliminary study 28 Comparison of the Low-level laser therapy effects on cultured human gingival fibroblasts proliferation using different irradiance and same fluence 29 5. Low-Level Laser Therapy - Other clinical indications 30 Efficiency of therapeutic ultrasound, Low-level laser and compression therapy for healing of venous leg ulcers 30 Low-level laser therapy of leg ulcer in sickle cell anemia 31 Laser acupuncture therapy for primary monosymptomatic nocturnal enuresis 32 Low reactive level laser therapy for mesenchymal stromal cells therapies – Review article 33 Effect of Low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy – A randomized controlled trial 34 4 5 1. LOW-level laSer THeraPY in reHABiliTATION TITLE: EFFICACY OF LOW-LEVEL LASER THERAPY IN THE MANAGEMENT OF NECK PAIN: A SYSTEMATIC REVIEW AND TITLE: ADDITIVE EFFECTS Of LOW-LEVEL LASER THERAPY META-ANALYSIS OF RANDOMISED PLACEBO OR ACTIVE- WITH EXERCISE ON SUBACROMIAL SYNDROME: A RANDOMISED, TREATMENT CONTROLLED TRIALS DOUBLE-BLIND, CONTROLLED TRIAL Authors: Roberta T. Chow, Mark I. Johnson, Rodrigo A. B Lopes-Martins, Jan M. Bjordal Authors: Seyyed Mohammad Jalil Abrisham, Mohammad Kermani-Alghoraishi, Rahil Ghahramani, Affiliations: University of Sydney, NW, Australia; Leeds Metropolitan University, Leeds, UK; Latife Jabbari, Hossein Jomeh, Maryam Zare University of Săo Paulo, Săo Paulo, Brazil; Bergen University College, Bergen, Norway; Affiliations: Shahid Sadoughi University of Medical Sciences, Yazd, Iran University of Bergen, Bergen, Norway Source: Clin Rheumatol. 2011 May; 30: 1341–1346 Source: Lancet 2009; 374: 1897-908 ABSTRACT: ABSTRACT: Introduction: Background: The subacromial syndrome is the most common source of shoulder pain. The mainstays Neck pain is a common and costly condition for which pharmacological management has of conservative treatment are non-steroidal anti-inflammatory drugs and exercise therapy. limited evidence of efficacy and side-effects. Low-level laser therapy (LLLT) is a relatively Recently, low-level laser therapy (LLLT) has been popularized in the treatment of various uncommon, non-invasive treatment for neck pain, in which non-thermal laser irradiation is musculoskeletal disorders. applied to sites of pain. We did a systematic review and metaanalysis of randomised controlled trials to assess the efficacy of LLLT in neck pain. Purpose: The aim of this study is to evaluate the additive effects of LLLT with exercise in comparison with Methods: exercise therapy alone in treatment of the subacromial syndrome. We searched computerised databases comparing efficacy of LLLT using any wavelength with placebo or with active control in acute or chronic neck pain. Effect size for the primary Materials and Methods: outcome, pain intensity, was defined as a pooled estimate of mean difference in change in mm We conducted a randomized clinical study of 80 patients who presented to clinic with on 100 mm visual analogue scale. subacromial syndrome (rotator cuff and biceps tendinitis). Patients were randomly allocated into two groups. In group I (n=40), patients were given laser treatment (pulsed infrared laser) Findings: and exercise therapy for ten sessions during a period of 2 weeks. In group II (n=40), placebo We identified 16 randomised controlled trials including a total of 820 patients. In acute laser and the same exercise therapy were given for the same period. Patients were evaluated neck pain, results of two trials showed a relative risk (RR) of 1,69 (95% CI 1,22–2,33) for pain for the pain with visual analogue scale (VAS) and shoulder range of motion (ROM) in an active improvement of LLLT versus placebo. Five trials of chronic neck pain reporting categorical data and passive movement of flexion, abduction and external rotation before and after treatment. In showed an RR for pain improvement of 4,05 (2,74–5,98) of LLLT. Patients in 11 trials reporting both groups, significant post-treatment improvements were achieved in all parameters (P=0.00). changes in visual analogue scale had pain intensity reduced by 19,86 mm (10,04–29,68). Seven In comparison between the two groups, a significant improvement was noted in all movements trials provided follow-up data for 1–22 weeks after completion of treatment, with short-term in group I (P=0.00). Also, there was a substantial difference between the groups in VAS scores pain relief persisting in the medium term with a reduction of 22,07 mm (17,42–26,72). Side- (P=0.00) which showed significant pain reduction in group I. effects from LLLT were mild and not different from those of placebo. Results and conclusion: Conclusion: Our study indicates that LLLT combined with exercise therapy is more effective than exercise We show that LLLT reduces pain immediately after treatment in acute neck pain and up to 22 therapy alone in relieving pain and in improving the shoulder joint ROM in patients with weeks after completion of treatment in patients with chronic neck pain. subacromial syndrome (rotator cuff and biceps tendinitis), but further studies with larger samples, longer term findings and possible comparisons with other conservative interventions are needed to establish the effectiveness of this protocol. 6 7 TITLE: EVALUATION OF LOW-LEVEL THERAPY EFFECTIVENESS TITLE: A RANDOMISED, PLACEBO CONTROLLED TRIAL OF ON THE PAIN AND MASTICATORY PERFORMANCE OF PATIENTS LOW-LEVEL LASER THERAPY FOR ACTIVATED ACHILLES TENDINITIS WITH MYOFASCIAL PAIN WITH MICRODIALYSIS MEASUREMENT OF PERITENDINOUS PROSTAGLANDIN E2 CONCENTRATIONS Authors: Mila Leite de Moraes Maia, Maria Amália Gonzaga Ribeiro, Luiz Guilherme Martins Maia, Juliana Stuginski-Barbosa, Yuri Martins Costa, André Luís Porporatti, Paulo César Rodrigues Authors: J. M. Bjordal, R. A. B. Lopes-Martins, V. V. Iversen Conti, Leonardo Rigoldi Bonjardim Affiliations: University of Bergen, Bergen, Norway Affiliations: Federal University of Sergipe, Sergipe, Brazil; Tiradentes Univesity, Tiradentes, Brazil; Source: Br. J. Sports Med. 2006; 40: 76-80 University of São Paulo, Bauru, Brazil Source: Lasers Med Sci. 2014; 29: 29-35 ABSTRACT: ABSTRACT: Introduction: Low-level laser therapy (LLLT) has gained increasing popularity in the management of tendinopathy Background: and arthritis. Results from in vitro and in vivo studies have suggested that inflammatory modulation is Study investigated the effect of low-level laser therapy (LLLT) on the masticatory performance one of several possible biological mechanisms of LLLT action. (MP), pressure pain threshold (PPT), and pain intensity in patients with myofascial pain. Objective: Methods: To investigate in situ if LLLT has an anti-inflammatory effect on activated tendinitis of the human Twenty-one subjects, with myofascial
Recommended publications
  • July 2020 Goal the Goal of the Residency Program Is to Develop Future Leaders in Both Research and Clinical Medicine

    July 2020 Goal the Goal of the Residency Program Is to Develop Future Leaders in Both Research and Clinical Medicine

    Residency Training Program July 2020 Goal The goal of the Residency Program is to develop future leaders in both research and clinical medicine. Flexibility within the program allows for the acquisition of fundamental working knowledge in all subspecialties of dermatology. All residents are taught a scholarly approach to patient care, aimed at integrating clinicopathologic observation with an understanding of the basic pathophysiologic processes of normal and abnormal skin. Penn’s Residency Program consists of conferences, seminars, clinical rotations, research, and an opportunity to participate in the teaching of medical students. An extensive introduction into the department and the William D. James, M.D. Director of Residency Program clinic/patient care service is given to first-year residents. A distinguished clinical faculty and research faculty, coupled with the clinical and laboratory facilities, provides residents with comprehensive training. An appreciation of and participation in the investigative process is an integral part of our residency. Graduates frequently earn clinical or basic science fellowship appointments at universities across the country. Examples of these include: pediatric dermatology, dermatopathology, dermatologic surgery, dermatoepidemiology, postdoctoral and Clinical Educator fellowships. Additional post graduate training has occurred at the NIH and CDC. Graduates of our program populate the faculty at Harvard, Penn, Johns Hopkins, MD Anderson, Dartmouth, Penn State, Washington University, and the Universities of Washington, Pittsburgh, Vermont, South Carolina, Massachusetts, Wisconsin, and the University of California San Francisco. Additionally, some enter private practice to become pillars of community medicine. Misha A. Rosenbach, M.D. Associate Director of Residency Program History The first medical school in America, founded in 1765, was named the College of Philadelphia.
  • FY20 National Laser Users' Facility Program

    FY20 National Laser Users' Facility Program

    FY20 NATIONAL LASER USERS’ FACILITY PROGRAM FY20 National Laser Users’ Facility Program M. S. Wei Laboratory for Laser Energetics, University of Rochester During FY19, the National Nuclear Security Administration (NNSA) and Office of Science jointly completed a funding opportu- nity announcement (FOA), review, and selection process for National Laser Users’ Facility (NLUF) experiments to be conducted at the Omega Facility during FY20 and FY21. After peer review by an independent proposal review committee for scientific and technical merit and the feasibility review by the Omega Facility team, NNSA selected 11 proposals for funding and Omega shot allocation with a total of 22.5 and 23.5 shot days for experiments in FY20 and FY21, respectively. During the first half of the FY20, LLE completed a one-time solicitation, review, and selection process for Academic and Industrial Basic Science (AIBS) experiments to utilize the remaining NLUF shot allocation in FY20–FY21. Ten new projects were selected for AIBS shot alloca- tion (a total of 11 and 10 shot days) for experiments staring in Q3FY20 and throughout FY21. FY20 was the first of a two-year period of performance for these 21 NLUF including AIBS projects (Table I). Fifteen NLUF and AIBS projects obtained a total of 232 target shots during FY20, which are summarized in this section. A critical part of the NNSA-supported NLUF program and the DOE Office of Fusion Energy Sciences (FES)-supported Laser- NetUS program is the education and training of graduate students in high-energy-density (HED) physics. In addition, graduate students can also access the Omega Laser Facility to conduct their theses research through collaborations with national labora- tories and LLE.
  • Soft Tissue Laser Dentistry and Oral Surgery Peter Vitruk, Phd

    Soft Tissue Laser Dentistry and Oral Surgery Peter Vitruk, Phd

    Soft Tissue Laser Dentistry and Oral Surgery Peter Vitruk, PhD Introduction The “sound scientific basis and proven efficacy in order to ensure public safety” is one of the main eligibility requirements of the ADA CERP Recognition Standards and Procedures [1]. The outdated Laser Dentistry Curriculum Guidelines [2] from early 1990s is in need of an upgrade with respect to several important laser-tissue interaction concepts such as Absorption Spectra and Hot Glass Tip. This position statement of The American Board of Laser Surgery (ABLS) on soft tissue dentistry and oral surgery is written and approved by the ABLS’s Board of Directors. It focuses on soft tissue ablation and coagulation science as it relates to both (1) photo-thermal laser-tissue interaction, and (2) thermo-mechanical interaction of the hot glass tip with the tissue. Laser Wavelengths and Soft Tissue Chromophores Currently, the lasers that are practically available to clinical dentistry operate in three regions of the electromagnetic spectrum: near-infrared (near-IR) around 1,000 nm, i.e. diode lasers at 808, 810, 940, 970, 980, and 1,064 nm and Nd:YAG laser at 1,064 nm; mid-infrared (mid-IR) around 3,000 nm, i.e. erbium lasers at 2,780 nm and 2,940 nm; and infrared (IR) around 10,000 nm, i.e. CO2 lasers at 9,300 and 10,600 nm. The primary chromophores for ablation and coagulation of oral soft tissue are hemoglobin, oxyhemoglobin, melanin, and water [3]. These four chromophores are also distributed spatially within oral tissue. Water and melanin, for example, reside in the 100-300 µm-thick epithelium [4], while water, hemoglobin, and oxyhemoglobin reside in sub-epithelium (lamina propria and submucosa) [5], as illustrated in Figure 1.
  • A Programmable Mode-Locked Fiber Laser Using Phase-Only Pulse Shaping and the Genetic Algorithm

    A Programmable Mode-Locked Fiber Laser Using Phase-Only Pulse Shaping and the Genetic Algorithm

    hv photonics Article A Programmable Mode-Locked Fiber Laser Using Phase-Only Pulse Shaping and the Genetic Algorithm Abdullah S. Karar 1,* , Raymond Ghandour 1 , Ibrahim Mahariq 1 , Shadi A. Alboon 1,2, Issam Maaz 1, Bilel Neji 1 and Julien Moussa H. Barakat 1 1 College of Engineering and Technology, American University of the Middle East, Kuwait; [email protected] (R.G.); [email protected] (I.M.); [email protected] (S.A.A.); [email protected] (I.M.); [email protected] (B.N.); [email protected] (J.M.H.B.) 2 Electronics Engineering Department, Hijjawi Faculty for Engineering Technology, Yarmouk University, Irbid 21163, Jordan * Correspondence: [email protected] Received: 24 July 2020; Accepted: 2 September 2020; Published: 4 September 2020 Abstract: A novel, programmable, mode-locked fiber laser design is presented and numerically demonstrated. The laser programmability is enabled by an intracavity optical phase-only pulse shaper, which utilizes the same linearly chirped fiber Bragg grating (LC-FBG) from its two opposite ends to perform real-time optical Fourier transformation. A binary bit-pattern generator (BPG) operating at 20-Gb/s and producing a periodic sequence of 32 bits every 1.6 ns, is subsequently used to drive an optical phase modulator inside the laser cavity. Simulation results indicate stable programmable intensity profiles for each optimized user defined 32 code words. The laser operated in the self-similar mode-locking regime, enabling wave-breaking free operation. The programmable 32 bit code word targeting a specific intensity profile was determined using 100 generations of the genetic algorithm.
  • General Dermatology Practice Brochure

    General Dermatology Practice Brochure

    Appointments Our Providers David A. Cowan, MD, FAAD We are currently accepting • Fellow, American Academy of Dermatology new patients. • Associate, American College of Call today to schedule your appointment Mohs Micrographic Surgery Monday - Friday, 8:00am to 4:30pm Rebecca G. Pomerantz, MD 1-877-661-3376 • Board Certified, American Academy of Cancellations & “No Show” Policy Dermatology If you are unable to keep your scheduled Lisa L. Ellis, MPAS, PA-C appointment, please call the office and we will • Member, American Academy of Physician be more than happy to reschedule for you. Assistants Failure to notify us at least 48 hours prior to your • Member, PA Society of Physician Assistants Medical and appointment may result in a cancellation fee. • Member, Society of Dermatology Physician Prescription Refills Assistants Surgical Refill requests are handled during normal office Sheri L. Rolewski, MSN, CRNP-BC hours when our staff has full access to medical • National Board Certification, Family Nurse Dermatology records. Refills cannot be called in on holidays, Practitioner Specialty weekends or more than twelve months after your • Member, Dermatology Nurse Association last exam. Please have your pharmacy contact our office directly. Test Results SMy Dermatology Appointment You will be notified when we receive your Date/Day _____________________________________ pathology or other test results, usually within two weeks from the date of your procedure. If you Time _________________________________________ do not hear from us within three
  • Dermatology at the Berkeley Outpatient Center

    Dermatology at the Berkeley Outpatient Center

    Dermatology Berkeley Outpatient Center Overview Encompassing both medical and cosmetic dermatology, our experts at the Berkeley Outpatient Center offer a full range of diagnostic, treatment and surgical services for patients with cutaneous conditions. Surgical Dermatology • Fellowship-trained expertise in • Close coordination with Plastic Surgery Mohs micrographic surgery for at the Berkeley Outpatient Center, treatment of skin cancers including allowing for streamlined treatment for basal cell carcinomas and squamous related procedures in one location cell carcinomas, as well as treatment of • Outpatient surgery for removal of melanoma in situ with MART-1 staining benign skin growths and skin cancers Medical Dermatology - Conditions Treated/Services Offered • Acne, rosacea and related conditions • Mole/Atypical nevus/Melanoma • Sun-damaged skin surveillance • Aesthetic/Cosmetic dermatology • Non-melanoma skin cancers • Eczema and atopic dermatitis • Pigmentation disorders • HIV/AIDS-related skin conditions • Psoriasis • Lumps under the skin • Rashes • Infections of the skin (bacterial, viral, • Skin checks for patients with fungal and other) concerning lesions • Melanoma • Warts When to see a Dermatologist For more information, please call Dermatology Services at (510) 985-5200. Dermatology Services Providing integrated care in the community. Our Dermatology Team Erin Amerson, MD Drew Saylor, MD, MPH UCSF Health UCSF Health Dermatologist Dermatologic surgeon To learn more about our doctors, visit ucsfhealth.org/find_a_doctor. Office location: Berkeley Outpatient Center 3100 San Pablo Avenue Berkeley, CA 94702 (510) 985-5200 To learn more about our Berkeley Outpatient Center, Adeline St visit johnmuirhealth.com/ September 2020 berkeleyopc..
  • MRI-Guided Laser Ablation Surgery of Hypothalamic Hamartomas

    MRI-Guided Laser Ablation Surgery of Hypothalamic Hamartomas

    NEUROSURGERY MRI-Guided Laser Ablation Surgery of Hypothalamic Hamartomas HOW DOES THE TEAM DECIDE IF A PATIENT IS A CANDIDATE FOR MRI-GUIDED LASER ABLATION? A careful review of each patient’s medical records is the first step, including MR imaging of the brain and any applicable neurology or neurosurgery records. Patients with Hypothalamic Hamartomas (HH) typically have gelastic seizures, which are characterized by emotionless laughing, although variations including abnormal movements or staring spells are also common. Every patient’s case is handled individually, and it may be necessary for a patient to come to Texas Children’s Hospital for further testing to determine if they are a candidate for MRI-guided laser ablation surgery. WHAT HAPPENS DURING MRI-GUIDED LASER ABLATION SURGERY? After being placed under general anesthesia, a head frame, or a set of markers, is fitted to the patient’s skull. A CT scan is completed to orient the brain to the frame in 3 dimensions. With the help of computer software, a safe pathway that goes through the brain to the HH is calculated for the laser. The neurosurgeon then makes a small incision and drills a small hole through the skull (3.2 mm wide). The laser applicator, a small tube about the width of a strand of spaghetti, is inserted and guided through the brain into the HH. Once the laser applicator is inserted into the brain, the head frame is removed, and the patient is transported to the MRI scanner. After confirming proper placement of the laser applicator and setting safety markers, the surgeon performs a small test firing using the laser.
  • Cutaneous Laser Surgery

    Cutaneous Laser Surgery

    Cutaneous Laser Surgery Vineet Mishra, M.D. Director of Mohs Surgery & Procedural Dermatology Assistant Professor of Dermatology University of Texas Health Science Center – San Antonio Visible-Infrared Range What does it stand for? LASER 3 Components: – L Light – Pumping system – A Amplification . Energy source/power supply – S Stimulated – Lasing medium – E Emission – Optical cavity – R Radiation Lasing Medium Supplies electrons for the stimulated emission of radiation Determines wavelength of laser – Expressed in nm 3 Mediums: – Gaseous (CO2, argon, copper vapor) – Solid (diode, ruby, Neodymium:Yag) – Liquid (tunable dye, pulse dye) Laser vs. IPL LASER – coherent, monochromatic light IPL = intense pulsed light – non coherent light – 515‐1000nm Monochromatc Laser light is a single color – color = specific wavelength of each laser Wavelength Wavelength determines – Chromophore specificity . Chromophore = tissue target that absorbs a specific wavelength of light – Depth pulse travels Chromophore & Absorption Spectra Chromophore/Target Wavelength Abs. Spectra – Hemoglobin – Blue-green and yellow light – DNA, RNA, protein – UV light – Melanin – Ultraviolet > Visible >> near IR – Black ink tattoo – Visible and IR – Water – IR Absorption Curves Terms to Know Energy – Joules, the capacity to do work Power – Rate of energy delivery (Watts = J/sec) Fluence – Energy density (J/cm2) Thermal Relaxation Time (TRT) – time required for an object to lose 50% of its absorbed heat (cooling time) to surrounding tissues Thermal Relaxation Time Thermal Relaxation Time (TRT) – time required for an object to lose 50% of its absorbed heat (cooling time) to surrounding tissues – directly proportional to size of an object (proportional to square of its size) – smaller objects cool faster (shorter TRT) than larger ones (longer TRT) Selective Photothermolysis by Anderson and Parrish (Science, 1983) Selective Photothermolysis – Thermocoagulation of specific tissue target with minimum damage to surrounding tissue Requirements: – 1.
  • Dermatology Patch Allergy Testing Post Service - Information Request Form

    Dermatology Patch Allergy Testing Post Service - Information Request Form

    Dermatology Patch Allergy Testing Post Service - Information Request Form Blue Cross NC will review associated claim(s) for services rendered on the patient listed below. In order to determine benefits are available for the reported condition, please answer the questions below. If you would prefer to send medical records, relating to the condition for the dates listed you may do so. In this case, all answers must be supported by documentation in the patient's medical record. Please submit the completed form to Blue Cross NC per the Medical Record Submission instructions found on the bcbsnc.com provider site (https://www.bcbsnc.com/assets/providers/public/pdfs/submissions/how_to_submit_provider_initiated_medical_records.pdf) or if requested by Blue Cross NC via a bar-coded coversheet, please fax the form/medical records to the number noted on the bar-coded cover sheet within 7-10 days to facilitate the claim payment. This form must be filled out by the patient's physician or their designee which may be any of the following: Physician Assistant (PA), Nurse Practitioner (NP), Registered Nurse (RN), or Licensed Practical Nurse (LPN). Note: Credentials must be provided with signature or the form will be returned. PROVIDER INFORMATION Requesting Provider Information Place of Service Provider Name Facility Name Provider ID Facility ID PATIENT INFORMATION Patient Name:_____________________________ Patient DOB :_____________ Patient Account Number______________ Patient ID:______________ CLAIM INFORMATION Date(s) of Service_____________ CPT_________ Diagnosis_______ Dermatology Patch Allergy Testing - Information Request Form Page 1 of 3 CLINICAL INFORMATION Did the patient have direct skin testing (for immediate hypersensitivity) by: Percutaneous or epicutaneous (scratch, prick, or puncture)? ________________ Intradermal testing? ___________________________________ Inhalant allergy evaluation? _________________ Did the patient have patch (application) testing (most commonly used: T.R.U.E.
  • Fundamentals of Dermatology Describing Rashes and Lesions

    Fundamentals of Dermatology Describing Rashes and Lesions

    Dermatology for the Non-Dermatologist May 30 – June 3, 2018 - 1 - Fundamentals of Dermatology Describing Rashes and Lesions History remains ESSENTIAL to establish diagnosis – duration, treatments, prior history of skin conditions, drug use, systemic illness, etc., etc. Historical characteristics of lesions and rashes are also key elements of the description. Painful vs. painless? Pruritic? Burning sensation? Key descriptive elements – 1- definition and morphology of the lesion, 2- location and the extent of the disease. DEFINITIONS: Atrophy: Thinning of the epidermis and/or dermis causing a shiny appearance or fine wrinkling and/or depression of the skin (common causes: steroids, sudden weight gain, “stretch marks”) Bulla: Circumscribed superficial collection of fluid below or within the epidermis > 5mm (if <5mm vesicle), may be formed by the coalescence of vesicles (blister) Burrow: A linear, “threadlike” elevation of the skin, typically a few millimeters long. (scabies) Comedo: A plugged sebaceous follicle, such as closed (whitehead) & open comedones (blackhead) in acne Crust: Dried residue of serum, blood or pus (scab) Cyst: A circumscribed, usually slightly compressible, round, walled lesion, below the epidermis, may be filled with fluid or semi-solid material (sebaceous cyst, cystic acne) Dermatitis: nonspecific term for inflammation of the skin (many possible causes); may be a specific condition, e.g. atopic dermatitis Eczema: a generic term for acute or chronic inflammatory conditions of the skin. Typically appears erythematous,
  • Concepts of Sliding and Lifting Tissue Movement in Flap Reconstruction

    Concepts of Sliding and Lifting Tissue Movement in Flap Reconstruction

    HOW I DO IT/BACK TO BASICS This new feature will emphasize innovative and better ways to perform dermatologic surgery procedures. This ar- ticle should be based on some evidence-based literature, but may describe the author’s experience with a particular procedure without being a typical clinical research article. The Editor will consider ideas for topics. Any author who is considering writing an article should submit the title to Ronald L. Moy, MD, Editor-in-Chief, 100 UCLA Medical Plaza, Suite 590, Los Angeles, CA 90024. Concepts of Sliding and Lifting Tissue Movement in Flap Reconstruction Timothy M. Johnson, MD,*†‡ Neil Swanson, MD,§ and Shan R. Baker, MD† Departments of *Dermatology, †Otorhinolaryngology, and ‡Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, and §Department of Dermatology and Otolaryngology, Oregon Health Sciences, Portland Oregon background. The optimal design of a skin flap requires an the answer to three predictable events that result from tissue understanding of the concepts of tissue movement. transfer: Where is the tension? Where are the final incision objective. The purpose of this manuscript was to demon- lines? Where is the redundant tissue? strate concepts of sliding and lifting tissue movement for flap conclusion. A mental exercise assessing all available recon- reconstruction. struction options should be performed for each individual pa- methods. Six similar defects located in the forehead–temple– tient and defect. Both patient and defect considerations need to eyebrow region were repaired using a different skin flap. be assessed. A thorough understanding of both anatomy and tis- results. The specific flap design for a given defect is based on sue movement is necessary for optimal skin flap reconstruction.
  • Experts Describe the Gold Standard in Medical

    Experts Describe the Gold Standard in Medical

    Christopher Zachary, MBBS, FRCP Experts describe the gold standard in Professor and Chair Department of Dermatology medical and aesthetic laser therapy, University of California-Irvine sharing their experiences using clinically- effective, time-proven technologies. asers have without question revolutionized the practice Expanding the Level of Service and ® of dermatology, permitting clinicians to treat conditions Patient Satisfaction with Gemini for which no medical therapies exist or offering results Efficient Management of Rosacea and Photodamage that exceed those of conventional therapeutics. From with the Gemini Laser medical conditions like acne and rosacea to cosmetic Lrejuvenation, laser systems can address a variety of the most Photorejuvenation in Asian Skin Tones: common presentations that bring patients to the dermatolo- Role of the Gemini Laser gist’s office. Gemini for Photorejuvenation: Given their remarkable utility, well-designed and manufac- A Cornerstone of the Cosmetic Practice tured lasers can be a tremendous asset to dermatologists. Yet, often physicians are overwhelmed by the prospect of incorpo- Targeting Patients’ Aesthetic Goals with the VariLite™ rating laser procedures into practice. Technology is costly, and there may be a tremendous sense of pressure to attract The VariLite for Fundamental Cosmetic Applications patients and, as important, provide treatment that meets their VariLite: A Reliable, Predictable Tool for Vascular and goals. There may also be a learning curve, as residency pro- Pigmented Lesions grams currently offer little training in aesthetic dermatology, Continued on page 3 Expert Contributors William Baugh, MD C. William Hanke, MD, MPH Assistant Clinical Professor, Visiting Professor of Dermatology, Western School of Medicine University of Iowa, Carver College of Medicine Medical Director Clinical Professor of Otolaryngology Head and Full Spectrum Dermatology, Neck Surgery, Fullerton, CA Indiana University School of Medicine Carmel, IN Henry H.